Skip to main content
SpringerLink
Log in
Book cover

Cholestatic Liver Disease pp 171–181Cite as

Cholestasis Post Liver Transplantation

  • Chapter

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

Cholestasis occurs frequently after liver transplantation and has a very broad differential diagnosis. Cholestasis can occur anytime throughout the posttransplant period and may be intrahepatic or extrahepatic in origin. This chapter reviews the common causes of cholestasis in the posttransplant setting.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nemec P, Ondrasek J, Studenik P, Hokl J, and Cerny J. Biliary complications in liver transplantation. Ann Transplant 2001; 6(2): 24–28.

    CAS  PubMed  Google Scholar 

  2. Kusano T, Randall HB, Roberts JP, and Ascher NL. The use of stents for duct-to-duct anastomoses of biliary reconstruction in orthotopic liver transplantation. Hepatogastroenterology 2005; 52(63): 695–699.

    PubMed  Google Scholar 

  3. Thethy S, Thomson BNJ, Pleass H, et al. Management of biliary tract complications after orthotopic liver transplantation. Clin Transplant 2004; 18(6): 647–653.

    Article  PubMed  Google Scholar 

  4. Scatton O, Meunier B, Cherqui D, et al. Randomized trial of choledocho-choledochostomy with or without a T-tube in orthotopic liver transplantation. Ann Surg 2001; 233(3): 432–437.

    Article  CAS  PubMed  Google Scholar 

  5. Zoepf T, Maldonado-Lopez EJ, Hilgard P, et al. Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation. Liver Transplant 2006; 12(1): 88–94.

    Article  Google Scholar 

  6. Guichelaar MM, Benson JT, Malinchoc M, et al. Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant 2003; 3(7): 885–890.

    Article  PubMed  Google Scholar 

  7. Sanchez-Urdazpal L, Batts KP, Gores GJ, et al. Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg 1993; 218(2): 152–158.

    Article  CAS  PubMed  Google Scholar 

  8. Cadranel JF, Erlinger S, Desruenne M, et al. Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man. Dig Dis Sci 1992; 37(10): 1473–1476.

    Article  CAS  PubMed  Google Scholar 

  9. Busquets J, Figueras J, Serrano T, et al. Postreperfusion biopsies are useful in predicting complications after liver transplantation. Liver Transplant 2001; 7(5): 432–435.

    Article  CAS  Google Scholar 

  10. Lee YM, Obrien CB, Yamashiki N, et al. Preservation injury patterns in liver transplantation associated with poor prognosis. Transpl Proc 2003; 35: 2964–2966.

    Article  Google Scholar 

  11. Cutrin JC, Cantino D, Biasi F, et al. Reperfusion damage to the bile canaliculi in transplanted human liver. Hepatology 1996; 24(5): 1053–1057.

    Article  CAS  PubMed  Google Scholar 

  12. Kukan M, and Haddad PS. Role of hepatocytes and bile duct cells in preservationreperfusion injury of liver grafts. Liver Transplant 2001; 7(5): 381–400.

    Article  CAS  Google Scholar 

  13. Abt P, Crawford M, Desai N, et al. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation 2003; 75(10): 1659–1663.

    Article  PubMed  Google Scholar 

  14. Nakanuma Y, and Sasaki M. Expression of blood group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepatology 1989; 10(2): 174–178.

    Article  CAS  PubMed  Google Scholar 

  15. Dahm F, Georgiev P, and Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 2005; 5(11): 2605–2610.

    Article  PubMed  Google Scholar 

  16. Deltenre P, and Valla DC. Ischemic cholangiopathy. J Hepatol 2006; 44: 806–817.

    Article  PubMed  Google Scholar 

  17. Jain A, Costa G, Marsh W, et al. Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients. Transplant Int 2006; 19(1): 27–37.

    Article  Google Scholar 

  18. Silva MA, Jambulingam PS, Gunson BK, et al. Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom. Liver Transplant 2006; 12(1): 146–151.

    Article  Google Scholar 

  19. Pastacaldi S, Teixeira R, Montalto P, Rolles K, and Burroughs AK. Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transplant 2001; 7: 75–81.

    Article  CAS  Google Scholar 

  20. Levy GA, and Marsden PA. Cigarette smoking—association with hepatic artery thrombosis. Liver Transplant 2002; 8(7): 588–590.

    Article  Google Scholar 

  21. Pinna AD, Smith CV, Furukawa H, Starzl TE, and Fung JJ. Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation 1996; 62: 1584–1587.

    Article  CAS  PubMed  Google Scholar 

  22. Kusne S, and Blair JE. Viral and fungal infections after liver transplantation⇆art II Liver Transplant 2006; 12(1): 2–11.

    Google Scholar 

  23. Trauner M, Fickert P, and Stauber RE. Inflammation-induced cholestasis J Gastroenterol Hepatol 1999; 14(10): 946–959.

    Article  CAS  PubMed  Google Scholar 

  24. Lefkowitch JH. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and “cholangitis lenta” Hum Pathol 1982; 13(1): 19–24.

    Article  CAS  PubMed  Google Scholar 

  25. Paya CV, Hermans PE, Wiesner RH, et al. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations J Infect Dis 1989; 160(5): 752–758.

    CAS  PubMed  Google Scholar 

  26. Martelius T, Krogerus L, Hockerstedt K, Bruggeman C, and Lautenschlager I. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology 1998; 27(4): 996–1002.

    Article  CAS  PubMed  Google Scholar 

  27. Evans PC, Coleman N, Wreghitt TG, Wight DG, and Alexander GJ. Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts. J Hepatol 1999; 31(5): 913–920.

    Article  CAS  PubMed  Google Scholar 

  28. Lautenschlager I, Hockerstedt K, and Taskinen E. Histologic findings associated with CMV infection in liver transplantation. Transplant Proc 2003; 35(2): 819.

    Article  CAS  PubMed  Google Scholar 

  29. Lautenschlager I, Lappalainen M, Linnavuori K, Suni J, and Hockerstedt K CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients J Clin Virol 2002; 25(Suppl 2): S57–S61.

    Article  PubMed  Google Scholar 

  30. Chan FK, and Shaffer EA. Cholestatic effects of cyclosporine in the rat. Transplantation 1997; 63(11): 1574–1578.

    Article  CAS  PubMed  Google Scholar 

  31. Deters M, Klabunde T, Kirchner G, Resch K, and Kaever V. Sirolimus/ cyclosporine/tacrolimus interactions on bile flow and biliary excretion of immunosuppressants in a subchronic bile fistula rat model. Br J Pharmacol 2002; 136(4): 604–612.

    Article  CAS  PubMed  Google Scholar 

  32. Sanchez-Campos S, Lopez-Acebo R, Gonzalez P, et al. Cholestasis and alterations of glutathione metabolism induced by tacrolimus (FK506) in the rat. Transplantation 1998; 66(1): 84–88.

    Article  CAS  PubMed  Google Scholar 

  33. Deters M, Kirchner G, Koal T, Resch K, and Kaever V. Everolimus/cyclosporine interactions on bile flow and biliary excretion of bile salts and cholesterol in rats. Dig Dis Sci 2004; 49(1): 30–37.

    Article  CAS  PubMed  Google Scholar 

  34. Romagnuolo J, Sadowski DC, Lalor E, Jewell L, and Thomson AB. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity. Can J Gastroenterol 1998; 12(7): 479–483.

    CAS  PubMed  Google Scholar 

  35. Vierling JM, and Fennell RH. Jr. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts Hepatology 1985; 5(6): 1076–1082.

    Article  CAS  PubMed  Google Scholar 

  36. Nawaz S, and Fennell RH. Apoptosis of bile duct epithelial cells in hepatic allograft rejection. Histopathology 1994; 25(2): 137–142.

    Article  CAS  PubMed  Google Scholar 

  37. Savier E, Lemasters JJ, and Thurman RG. Kupffer cells participate in rejection following liver transplantation in the rat. Transplant Int 1994; 7(Suppl 1): S183–S186.

    Article  Google Scholar 

  38. Neuberger J. Incidence, timing, and risk factors for acute and chronic rejection. Liver Transplant Surg 1999; 5(4 Suppl 1): S30–S36.

    CAS  Google Scholar 

  39. Batts KP. Acute and chronic hepatic allograft rejection: pathology and classification. Liver Transplant Surg 1999; 5(4 Suppl 1): S21–S29.

    CAS  Google Scholar 

  40. Demetris AJ, Murase N, Ye Q, et al. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 1997; 150(2): 563–578.

    CAS  PubMed  Google Scholar 

  41. Neuberger J. Recurrent primary biliary cirrhosis. Liver Transplant 2003; 9(6): 539–546.

    Article  Google Scholar 

  42. Sylvestre PB, Batts KP, Burgart LJ, Poterucha JJ, and Wiesner RH. Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history. Liver Transplant 2003; 9(10): 1086–1093.

    Article  Google Scholar 

  43. Jacob DA, Neumann UP, Bahra M, Langrehr JM, and Neuhaus P. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. Transplant Proc 2005; 37(4): 1691–1692.

    Article  CAS  PubMed  Google Scholar 

  44. Graziadei IW, Wiesner RH, Marotta PJ, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30(5): 1121–1127.

    Article  CAS  PubMed  Google Scholar 

  45. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997; 225(5): 472–481.

    Article  CAS  PubMed  Google Scholar 

  46. Brandsaeter B, Schrumpf E, Bentdal O, et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transplant 2005; 11(11): 1361–1369.

    Article  Google Scholar 

  47. Kugelmas M, Spiegelman P, Osgood MJ, et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transplant 2003; 9(7): 727–732.

    Article  Google Scholar 

  48. Burak K, Angulo P, Pasha TM, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004; 99(3): 523–526.

    Article  PubMed  Google Scholar 

  49. Taga SA, Washington MK, Terrault N, et al. Cholestatic hepatitis C in liver allografts. Liver Transplant Surg 1998; 4(4): 304–310.

    Article  CAS  Google Scholar 

  50. Cotler SJ, Taylor SL, Gretch DR, et al. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients. Am J Gastroenterol 2000; 95(3): 753–759.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic, Rochester, MN

    Kymberly D. S. Watt MD

  2. University of Nebraska, Omaha, NE

    Timothy M. McCashland MD

Authors
  1. Kymberly D. S. Watt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy M. McCashland MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Mayo Clinic, Rochester, MN

    Keith D. Lindor MD  & Jayant A. Talwalkar MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Watt, K.D.S., McCashland, T.M. (2008). Cholestasis Post Liver Transplantation. In: Lindor, K.D., Talwalkar, J.A. (eds) Cholestatic Liver Disease. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-59745-118-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-118-5_10

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-838-6

  • Online ISBN: 978-1-59745-118-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation